+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Atherosclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 389 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 387 Pages
  • Global
From
From
Edema Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Edema Clinical Trials - Global Strategic Business Report

  • Report
  • October 2026
  • 461 Pages
  • Global
From
Urokinase - Global Strategic Business Report - Product Thumbnail Image

Urokinase - Global Strategic Business Report

  • Report
  • October 2026
  • 279 Pages
  • Global
From
Telmisartan - Global Strategic Business Report - Product Thumbnail Image

Telmisartan - Global Strategic Business Report

  • Report
  • October 2026
  • 477 Pages
  • Global
From
Dyslipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 268 Pages
  • Global
From
Losartan - Global Strategic Business Report - Product Thumbnail Image

Losartan - Global Strategic Business Report

  • Report
  • October 2026
  • 384 Pages
  • Global
From
Barth Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Barth Syndrome Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 486 Pages
  • Global
From
Lisinopril - Global Strategic Business Report - Product Thumbnail Image

Lisinopril - Global Strategic Business Report

  • Report
  • October 2026
  • 476 Pages
  • Global
From
From
Polypill Products - Global Strategic Business Report - Product Thumbnail Image

Polypill Products - Global Strategic Business Report

  • Report
  • October 2026
  • 378 Pages
  • Global
From
Stroke Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Stroke Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 367 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 155 Pages
  • Global
From
Heparin - Global Strategic Business Report - Product Thumbnail Image

Heparin - Global Strategic Business Report

  • Report
  • October 2026
  • 546 Pages
  • Global
From
From
Quinidine Sulfate - Global Strategic Business Report - Product Thumbnail Image

Quinidine Sulfate - Global Strategic Business Report

  • Report
  • October 2026
  • 175 Pages
  • Global
From
Troponin - Global Strategic Business Report - Product Thumbnail Image

Troponin - Global Strategic Business Report

  • Report
  • October 2026
  • 290 Pages
  • Global
From
From
Statins - Global Strategic Business Report 2026 - Product Thumbnail Image

Statins - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 176 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more